Patent details

EP1715856 Title: ATOMOXETINE FORMULATIONS

Basic Information

Publication number:
EP1715856
PCT Application Number:
PCT/US/2004/043678
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048156939
PCT Publication Number:
WO/2005/065673
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ATOMOXETINE FORMULATIONS
French Title of Invention:
PREPARATIONS D'ATOMOXETINE
German Title of Invention:
ATOMOXETIN-FORMULIERUNGEN
SPC Number:

Dates

Filing date:
23/12/2004
Grant date:
11/07/2012
EP Publication Date:
11/07/2012
PCT Publication Date:
21/07/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/11/2006
EP B1 Publication Date:
11/07/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/12/2012
Expiration date:
23/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/08/2012
 
 

Name:
Actavis Group PTC ehf.
Address:
Reykjavikurvegi 76-78, 220 Hafnarfjordur, Iceland (IS)

Inventor

1

Name:
DUNDON Josephine
Address:
United States (US)

2

Name:
BOEHM Garth
Address:
United States (US)

Priority

Priority Number:
533517 P
Priority Date:
31/12/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/135;
Filing date Document type Number of pages